Summit Investment Advisors »

Y Mabs Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $60k 3.7k 16.26
2023-12-31 $18k 2.6k 6.82
2023-09-30 $14k 2.6k 5.45
2023-06-30 $18k 2.6k 6.79
2023-03-31 $13k 2.6k 5.01
2022-12-31 $12k 2.6k 4.43
2022-09-30 $38k 2.6k 14.37
2022-06-30 $40k 2.6k 15.12
2022-03-31 $31k 2.6k 11.72
2021-12-31 $43k 2.6k 16.26
2021-09-30 $75k 2.6k 28.36
2021-06-30 $89k 2.6k 33.65
2021-03-31 $80k 2.6k 30.25
2020-12-31 $131k 2.6k 49.53
2020-09-30 $102k 2.6k 38.56
2020-06-30 $114k 2.6k 43.10
2020-03-31 $53k 2.0k 26.12
2019-12-31 $63k 2.0k 31.05
2019-09-30 $46k 1.8k 25.96
2019-06-30 $41k 1.8k 23.14
2019-03-31 $15k 575 26.09
2018-12-31 $12k 575 20.87